RI-AG03

• Target:

  Microtubule Associated|||Others

• Related Pathways:

  Others|||Cytoskeletal Signaling

• Bioactivity:

  RI-AG03 is an orally active peptide inhibitor capable of crossing the blood-brain barrier, targeting Tau aggregation. It effectively inhibits Tau aggregation in both in vivo and in vitro models, improving associated neurodegenerative and behavioral phenotypes. RI-AG03 is applicable in research on Tauopathies such as Alzheimer's disease.

• Molecular Formula:

  C104H189N49O22

• Molecular Weight:

  2477.93

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C